Actively Recruiting

Age: 18Years - 50Years
FEMALE
NCT06643065

The Influence of the Vaginal Microbiome on Clinical Pregnancy in Patients Undergoing a Euploid Embryo Transfer: a Prospective Blinded Multicentre Cohort Study

Led by Fundación IVI · Updated on 2024-10-15

1573

Participants Needed

10

Research Sites

76 weeks

Total Duration

On this page

Sponsors

F

Fundación IVI

Lead Sponsor

J

Juno

Collaborating Sponsor

AI-Summary

What this Trial Is About

Microorganisms such as bacteria live naturally on and in the bodies and are of great importance for our health. In the female body, almost 10% of all microorganisms live in the reproductive organs and especially in the vagina. Healthy bacteria in the vagina can defend against harmful bacteria and infections. However, it occasionally happens that the balance between healthy and harmful bacteria is disturbed, and it is believed that this could potentially harm pregnancy. However, there is not much evidence to prove a connection between an imbalance in bacteria and having an unsuccessful pregnancy. For this reason, the goal of our study is to determine if women with certain vaginal bacteria are more likely to experience pregnancy failures. If the investigators find this to be true, patients undergoing fertility treatment might be recommended regular tests in the future. If an imbalance in bacteria is found, doctors could provide treatment to restore a healthy vaginal environment, potentially improving the chances of a successful pregnancy.

CONDITIONS

Official Title

The Influence of the Vaginal Microbiome on Clinical Pregnancy in Patients Undergoing a Euploid Embryo Transfer: a Prospective Blinded Multicentre Cohort Study

Who Can Participate

Age: 18Years - 50Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • ART patients undergoing the transfer of a euploid embryo
Not Eligible

You will not qualify if you...

  • Patients with a body mass index (BMI) ≥35

    • Patients with uncorrected uterine malformations
    • Patients with a unicornuate uterus
    • Patients with a bicornuate uterus
    • Patients with any type of submucosal myoma
    • Patients with an intramural myoma if ≥4 cm
    • Patients with severe adenomyosis (>50% of the uterine corpus affected as defined by the MUSA criteria [19])
    • Patients undergoing transfer of an embryo with a morphology score <4BC (according to the Gardner & Schoolcraft scoring system [18])
    • Patients undergoing transfer of a day-7 embryo
    • Patients who took antibiotics in the month prior to the embryo transfer (excluding antibiotics given following oocyte retrieval)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 10 locations

1

Ginefiv Barcelona

Barcelona, Barcelona, Spain, 08015

Actively Recruiting

2

IVI Barcelona

Barcelona, Barcelona, Spain, 08029

Actively Recruiting

3

IVI Bilbao

Bilbao, Bilbao, Spain, 48940

Actively Recruiting

4

IVI Madrid

Madrid, Madrid, Spain, 28023

Actively Recruiting

5

Ginefiv Madrid

Madrid, Madrid, Spain, 28043

Actively Recruiting

6

IVI Málaga

Málaga, Málaga, Spain, 29006

Actively Recruiting

7

Ginemed Sevilla

Seville, Sevilla, Spain, 41010

Actively Recruiting

8

IVI Valencia

Valencia, Valencia, Spain, 46015

Actively Recruiting

9

IVI Vigo

Vigo, Vigo, Spain, 36203

Actively Recruiting

10

IVI Zaragoza

Zaragoza, Zaragoza, Spain, 50018

Actively Recruiting

Loading map...

Research Team

K

Katharina Spath

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here